Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06058650
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Biopsy of Breast — PROCEDUREUndergo biopsy of breast
- Medical Device Usage and Evaluation — OTHERUtilization of the Stereo Navigator accessory
- Scintimammography — RADIATIONUndergo MBI
- Technetium Tc-99m Sestamibi — OTHERGiven IV
Study Details
This clinical trial tests how well molecular breast imaging (MBI) works to guide the collection of a breast biopsy in patients with a breast abnormality. Currently, a biopsy is often guided by either ultrasound or mammography in order to ensure that a sample of the correct part of the breast is taken. Sometimes a lesion or part of the lesion cannot be seen on ultrasound or mammography, and, therefore, a biopsy guided with ultrasound or mammography may not be always be accurate. Studies have shown that high resolution MBI may have potential to improve the detection of some breast tumors. This trial uses a new high-resolution MBI system that may help perform a biopsy using MBI.
Key Dates
- Start date
- Aug 26, 2021
- Status verified
- Sep 2025
- Primary completion
- Aug 26, 2026
- Completion
- Aug 26, 2026
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Part I (technetium Tc-99m sestamibi, MBI)Patients receive technetium Tc-99m sestamibi IV and undergo MBI on study.
- Experimental: Part II (technetium Tc-99m sestamibi, MBI, biopsy)Patients receive technetium Tc-99m sestamibi IV and undergo MBI. Patients whose breast lesions of interest are visualized on MBI then undergo breast biopsy using the Stereo Navigator accessory.
Primary Outcome Measure
Validation of timeframe [ Time Frame: Baseline ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Katie N. Hunt, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
Related Studies
- Quantitative Microvasculature Imaging for Breast Cancer Detection and MonitoringRecruiting · Mayo Clinic · Rochester, Minnesota
- Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.PHASE3 · Recruiting · BriaCell Therapeutics Corporation · Phoenix, Arizona
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- Correlation of Clinical Response to Pathologic Response in Patients With Early Breast CancerPHASE2 · Recruiting · Baylor Breast Care Center · Houston, Texas